top of page

Takeda and Roivant launch Myovant Sciences Ltd

Takeda and Roivant Sciences have launched Myovant Sciences Ltd., a biopharmaceutical company focused on delivering innovative women’s health and prostate cancer therapeutics.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page